Eustace AJ - Search Results

1

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis.

Walsh N, Kennedy S, Larkin AM, Tryfonopoulos D, Eustace AJ, Mahgoub T, Conway C, Oglesby I, Collins D, Ballot J, Ooi WS, Gullo G, Clynes M, Crown J, O'Driscoll L. Walsh N, et al. Among authors: eustace aj. Br J Cancer. 2010 Mar 30;102(7):1157-62. doi: 10.1038/sj.bjc.6605590. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234362 Free PMC article.

2

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.

Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N. Glynn SA, et al. Among authors: eustace aj. BMC Cancer. 2008 Jan 16;8:9. doi: 10.1186/1471-2407-8-9. BMC Cancer. 2008. PMID: 18199328 Free PMC article.

3

Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts.

Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Gottschalk M, et al. NMR Biomed. 2008 Oct;21(8):809-19. doi: 10.1002/nbm.1258. NMR Biomed. 2008. PMID: 18470962

4

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.

Eustace AJ, Crown J, Clynes M, O'Donovan N. Eustace AJ, et al. J Transl Med. 2008 Sep 29;6:53. doi: 10.1186/1479-5876-6-53. J Transl Med. 2008. PMID: 18823558 Free PMC article.

5

Prospects for non-immunological molecular therapeutics in melanoma.

Eustace AJ, Mahgoub T, Tryfonopoulos D, O'Donovan N, Crown J. Eustace AJ, et al. J BUON. 2010 Jan-Mar;15(1):9-18. J BUON. 2010. PMID: 20414921 Review.

6

Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.

Brougham DF, Ivanova G, Gottschalk M, Collins DM, Eustace AJ, O'Connor R, Havel J. Brougham DF, et al. Among authors: eustace aj. J Biomed Biotechnol. 2011;2011:158094. doi: 10.1155/2011/158094. Epub 2010 Sep 15. J Biomed Biotechnol. 2011. PMID: 20886062 Free PMC article.

7

2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell lines.

Eustace AJ, Dowling P, Henry M, Doolan P, Meleady P, Clynes M, Crown J, O'Donovan N. Eustace AJ, et al. J Proteomics. 2011 Apr 1;74(4):490-501. doi: 10.1016/j.jprot.2010.12.011. Epub 2011 Jan 13. J Proteomics. 2011. PMID: 21237296

8

Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.

Browne BC, Eustace AJ, Kennedy S, O'Brien NA, Pedersen K, McDermott MS, Larkin A, Ballot J, Mahgoub T, Sclafani F, Madden S, Kennedy J, Duffy MJ, Crown J, O'Donovan N. Browne BC, et al. Among authors: eustace aj. Breast Cancer Res Treat. 2012 Dec;136(3):717-27. doi: 10.1007/s10549-012-2260-9. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117852

9

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies.

McDermott M, Eustace AJ, Busschots S, Breen L, Crown J, Clynes M, O'Donovan N, Stordal B. McDermott M, et al. Among authors: eustace aj. Front Oncol. 2014 Mar 6;4:40. doi: 10.3389/fonc.2014.00040. eCollection 2014. Front Oncol. 2014. PMID: 24639951 Free PMC article.

10

HER2-family signalling mechanisms, clinical implications and targeting in breast cancer.

Elster N, Collins DM, Toomey S, Crown J, Eustace AJ, Hennessy BT. Elster N, et al. Among authors: eustace aj. Breast Cancer Res Treat. 2015 Jan;149(1):5-15. doi: 10.1007/s10549-014-3250-x. Epub 2014 Dec 27. Breast Cancer Res Treat. 2015. PMID: 25542271 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page